[{"address1": "Deutscher Platz 5a", "city": "Leipzig", "zip": "04103", "country": "Germany", "phone": "49 341 48792 40", "fax": "49 341 48792 39", "website": "https://www.vita34.de", "industry": "Medical Care Facilities", "sector": "Healthcare", "longBusinessSummary": "VITA 34 AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the company provides biobanking services, such as freezing sperm and storage of adipose tissue and the isolation of cells from the stored materials. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.", "fullTimeEmployees": 745, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jakub Julian Baran", "title": "Chairman of the Management Board & CEO", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tomasz Franciszek Baran", "title": "Vice President of the Management Board & Chief Commercial Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Santiago  Luengo", "title": "Managing Director of Secuvita", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 2, "previousClose": 4.52, "open": 4.52, "dayLow": 4.52, "dayHigh": 4.52, "regularMarketPreviousClose": 4.52, "regularMarketOpen": 4.52, "regularMarketDayLow": 4.52, "regularMarketDayHigh": 4.52, "beta": 0.641, "volume": 101, "regularMarketVolume": 101, "bid": 4.52, "ask": 5.52, "marketCap": 104416480, "fiftyTwoWeekLow": 4.52, "fiftyTwoWeekHigh": 6.98, "priceToSalesTrailing12Months": 1.3246956, "fiftyDayAverage": 5.99, "twoHundredDayAverage": 6.21275, "currency": "USD", "enterpriseValue": 81150568, "profitMargins": -0.00117, "floatShares": 7950801, "sharesOutstanding": 17431800, "heldPercentInsiders": 0.684, "heldPercentInstitutions": 0.026719999, "bookValue": 1.324, "priceToBook": 4.524169, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -92000, "trailingEps": -1.67, "enterpriseToRevenue": 1.03, "enterpriseToEbitda": 21.172, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "VTIAF", "underlyingSymbol": "VTIAF", "shortName": "VITA 34 AG", "longName": "VITA 34 AG", "firstTradeDateEpochUtc": 1412602200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "5ba7b2ce-0459-334d-b15c-6f0d606eb920", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.99, "recommendationKey": "none", "totalCash": 14443000, "totalCashPerShare": 0.829, "ebitda": 3833000, "totalDebt": 17814000, "quickRatio": 0.647, "currentRatio": 0.714, "totalRevenue": 78823000, "debtToEquity": 80.723, "revenuePerShare": 4.808, "returnOnAssets": -0.008169999, "returnOnEquity": -0.010369999, "freeCashflow": -2312125, "operatingCashflow": 10570000, "revenueGrowth": 0.06, "grossMargins": 0.37952998, "ebitdaMargins": 0.04863, "operatingMargins": -0.0551, "financialCurrency": "EUR", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]